PharmLabs

Home
PharmLabs

PharmLabs provides the cannabis community with lab testing and analytical services for Compliance Testing and Quality Assurance purposes.

14/01/2026

Quality cannabis starts with quality data. 📊🌿

At PharmLabs, laboratory testing isn’t just about numbers it’s about trust, education, and informed decision-making for brands and consumers alike.

💡 Fun fact: Did you know that two cannabis samples with the same THC percentage can produce completely different experiences due to their terpene profiles?

🧪 This Week’s Question: If you had direct access to a lab scientist, what question would you ask about cannabis or h**p testing?

It could be about: • potency results • terpene profiles • contaminants & safety standards • or how lab testing impacts product consistency

There are no wrong questions, only opportunities to learn and improve the industry together.
Share your thoughts in the comments and let’s keep the conversation going.

Have more questions or need testing support? Our team is here to help.

📍 PharmLabs | San Diego, CA 📞 Call or Text: (619) 356-0898 📧 Email: info@sdpharmlabs.com 🕘 Mon–Fri | 9am–5pm

09/01/2026

📊 BREAKING CANNABIS RESEARCH: UCLA Awarded $7.3M to Advance Groundbreaking Cannabis Science in 2026.

UCLA has received a major state research investment from the California Department of Cannabis Control to power comprehensive cannabis science spanning laboratory discovery, clinical research, public health, and policy insights.

🔍 What this research covers
 • 🧪 Synthetic Cannabinoids: Creating and evaluating rare cannabinoids to better understand their potency, potential therapeutic benefits, and safety profiles, foundational work for next‑gen cannabinoid therapeutics.
 • 🌿 Unregulated Market Dynamics: Investigating why consumers still buy from unregulated sources nearly a decade after legalization, including contaminant testing and field surveys. Findings will help shape public health strategies.
 • ❤️ Cardiovascular Effects: A controlled clinical study will assess both immediate and long‑term heart health impacts from smoked and oral cannabis, directly informing clinical care and consumer education.
 • 🍃 Terpenes & Flavor Regulation: Establishing validated reference standards for cannabis terpenes to support evidence‑based regulation and reduce risks linked to flavor additives especially those attractive to youth.

This funding reflects a data‑driven shift in cannabis research moving beyond anecdote and into rigorous scientific inquiry that will influence policy, public health, and regulatory standards nationwide.

✨ Why this matters: As legal cannabis markets grow, trusted scientific evidence is critical to protect consumers, inform practitioners, and guide regulators. UCLA’s research will help fill gaps in our understanding of both benefits and risks associated with cannabis use from molecular science to real‑world market behavior.

🔗 Learn more about these groundbreaking studies and how they’ll shape the future of cannabis science here ⬇️
ucla-receives-7-3m-for-wide-ranging-cannabis-research

05/01/2026

📊 On this week’s Myth or Fact we’re talking about accuracy and quality.
 ❓ Does Rapid lab testing always means quality and accuracy are compromised?

Absolutely not, this is a very common myth, modern lab science proves that speed and quality can go hand‑in‑hand. 🔬✨

In advanced laboratories, efficient workflows and automation systems help standardize repetitive processes like sample handling, labeling, and data capture which reduces manual error and improves consistency. Studies show that automation can significantly enhance accuracy while also speeding up turnaround times and increasing throughput.

💡 Bottom Line: Fast results don’t equal low quality when backed by rigorous quality assurance, automation, and expert oversight, a modern lab can deliver accurate, reliable, and rapid data every time.

👇 We want to hear from you! Did you think faster results meant lower accuracy? Tell us in the comments! ⬇️
  TurnaroundTime LabAutomation FastAccurateResults HealthcareScience DiagnosticTesting

31/12/2025

💬 Question of the Week: How Will Ma*****na Rescheduling Impact Cannabinoid Regulation?

With President Trump’s executive order to reschedule ma*****na from Schedule I to Schedule III, we’re seeing a potential shift in the way cannabis and cannabinoids are regulated at the federal level. But what does this really mean for cannabinoids like CBD, CBG, and other h**p-derived products?

Here’s what we know: 🔹 Rescheduling to Schedule III would acknowledge ma*****na’s medicinal potential, potentially allowing for more research opportunities and a clearer regulatory framework for cannabinoids. 🔹 This shift may also reduce the tax burden for cannabis businesses by eliminating 280E tax restrictions, which currently limit standard business deductions for cannabis operators. 🔹 However, questions remain: Will this rescheduling lead to federal clarity on CBD? Or are we still facing a fragmented regulatory landscape as the FDA and DEA navigate these complex rules?

As more states move towards legal cannabis, federal action is becoming increasingly important for cannabis companies, researchers, and consumers. The rescheduling could pave the way for more innovation and transparency in the cannabinoid market, but there’s still a lot of room for debate on how these changes will unfold.

🔍 What do you think?
 How do you believe ma*****na rescheduling will impact cannabinoid regulation? Will we see clearer guidelines for cannabinoids like CBD and THC? Or are we heading for more confusion with overlapping state and federal laws?

💬 Share your thoughts in the comments below! We want to hear your perspective!

🔗 Stay informed with PharmLabs as we continue to track the latest changes in cannabis regulations, research, and best practices. Follow us for up-to-date industry insights.

PharmLabs CannabisBusiness Cannabinoids CannabisPolicy FDA RegulatoryChanges CannabisCommunity HempIndustry Ma*****naPolicy CannabisUpdates

31/12/2025

🗞️ Industry News | Federal Cannabis Policy Update.

On December 18, 2025, President Trump signed an executive order instructing federal agencies to begin the process of rescheduling ma*****na from a Schedule I to a Schedule III controlled substance under the Controlled Substances Act.

📌 What does this mean? • The rescheduling process does not automatically change the law. Federal agencies like the DEA and Department of Justice (DOJ) must still go through formal rulemaking before any changes take effect.
 • Ma*****na remains illegal federally until the rulemaking process is complete, meaning state laws will continue to govern cannabis use, production, and sales.
 • Schedule III classification would help expand medical research, potentially lower tax burdens, and improve access to financial services for the cannabis industry.
 • Research and development: The reclassification could significantly reduce barriers to scientific studies on cannabis, helping researchers explore its medical potential.
 • Tax benefits: Cannabis businesses could benefit from a reduced tax burden by being able to deduct standard business expenses under tax code 280E.

📚 For more details on the executive order’s potential impacts, check out the full NPR article here:
 👉 https://www.npr.org/2025/12/26/nx-s1-5652027/ma*****na-reclassified-trump-executive-order

💬 We want to hear from you!
 How do you think this change in federal policy will impact the cannabis industry, research, or your business? Share your thoughts in the comments, we want to know what this means for you and your future operations.

🔬 Follow us for weekly updates on cannabis science, policy, best practices and much more.

📣 Stay informed. Stay compliant. Stay ahead.

*****naresearch 280E PharmLabs cannabismarketing cannabisbusiness industryupdate

16/12/2025

🎄 Holiday Hours Update 🎅🏽

As we head into the holiday season, we want to thank you for your continued trust in PharmLabs 🤍
 Please plan accordingly, as our laboratory will be closed and not accepting or processing samples on the following dates:

📅 December 24–26, 2026 📅 January 1, 2026

To help avoid any delays, we recommend scheduling submissions ahead of time. Our team will resume normal operations immediately following these closures.

Have questions about scheduling or turnaround times? 📧 care@sdpharmlabs.com
Wishing you a safe, restful, and joyful holiday season ✨
 🔬 PharmLabs | ISO/IEC 17025 Accredited 🌐 www.sdpharmlabs.com 📞 (619) 356-0898

16/12/2025

🎄 Holiday Hours Update 🧑‍🎄

As we head into the holiday season, we want to thank you for your continued trust in PharmLabs 🤍
 Please plan accordingly, as our laboratory will be closed and not accepting or processing samples on the following dates:

📅 December 24–26, 2026 📅 January 1, 2026

To help avoid any delays, we recommend scheduling submissions ahead of time. Our team will resume normal operations immediately following these closures.

Have questions about scheduling or turnaround times? 📧 care@sdpharmlabs.com
Wishing you a safe, restful, and joyful holiday season ✨
 🔬 PharmLabs | ISO/IEC 17025 Accredited 🌐 www.sdpharmlabs.com 📞 (619) 356-0898

16/12/2025

🌱 This weeks Myth or Fact Question:

Pesticide testing only looks for a few common chemicals?

❌ Myth.
Comprehensive pesticide testing involves screening for a broad range of regulated pesticide compounds, often spanning multiple chemical classes. Because each pesticide behaves differently at the molecular level, accurate detection requires specialized analytical methods and highly sensitive laboratory instrumentation capable of measuring residues at trace levels.

There is no single universal test for all pesticides. Instead, accredited laboratories rely on validated multi-method testing approaches, strict quality controls, and method verification to ensure results are accurate, reproducible, and compliant with regulatory standards.

Understanding the scope of pesticide testing helps brands interpret Certificates of Analysis (COAs) correctly, maintain product integrity, and support transparency throughout the supply chain. This is why third-party laboratory testing plays a critical role in quality assurance and compliance across regulated products.

💬 Question for you: Did you know pesticide testing involves multiple analytical approaches?

Share your thoughts/answers in the comments below.

➡️ Have questions about pesticide testing panels? Let’s talk.

🔬 ISO/IEC 17025 Accredited Analytical Laboratory
🌐 www.sdpharmlabs.com
📞 (619) 356-0898

16/12/2025

🍄 Question of the Week
What’s the difference between psilocybin and psilocin and why does it matter for analytical testing?
 Psilocybin is the more chemically stable compound, while psilocin is significantly less stable and degrades more easily. Because of this, psilocin requires stricter handling, storage, and validated analytical methods to be accurately measured in laboratory testing. Although closely related, psilocybin and psilocin behave very differently during analytical testing.

🔬 Psilocybin is the phosphorylated, more chemically stable compound. 🧪 Psilocin is the active metabolite and is significantly less stable, making it more susceptible to degradation from light, heat, oxygen, and handling.

Because of this, accurate analysis requires specialized sample preparation, validated analytical methods, and strict quality controls. Without these safeguards, reported results may not fully reflect compound presence or consistency.

This distinction is critical for research accuracy, data integrity, and reliable analytical reporting, especially when working with naturally variable materials. It’s one reason third-party laboratory testing and method validation are essential in advanced compound analysis.

💬 Did you know psilocybin and psilocin require different analytical considerations during testing?
 💾 Save this post for later | 🔄 Share with your team

📍 PharmLabs 🔬 ISO/IEC 17025 Accredited Analytical Laboratory 🧪 Trusted since 2011 🌐 www.sdpharmlabs.com 📞 (619) 356-0898

10/12/2025

Industry News 🚨

Early clinical studies are shedding new light on how psilocybin-assisted therapy may support patients in oncology and palliative care settings.

According to recent clinical reviews, psilocybin has shown promising potential in helping reduce anxiety, depression, and existential distress among individuals facing advanced or life-limiting cancer. These early-stage findings highlight meaningful improvements in emotional well-being and quality of life when treatment is administered in controlled, professionally supervised therapeutic environments.

While these results are encouraging, psilocybin-assisted therapy remains experimental and is not part of standard oncology treatment. Larger, long-term clinical trials are currently underway to better understand safety, efficacy, and appropriate therapeutic frameworks. As research evolves, rigorous analytical testing and compound verification remain essential to advancing safe, responsible scientific progress in this field.

📖 Read full article here: https://www.pharmacytimes.com/view/psychedelic-science-2025-clinical-perspectives-on-psychedelics-in-palliative-oncology

At PharmLabs, we are committed to supporting innovation across emerging therapeutic landscapes. Our ISO/IEC 17025-accredited laboratory provides validated analytical testing for cannabinoids, peptides, alkaloids, psychedelic compounds, and more empowering researchers, manufacturers, and healthcare innovators with precise and reliable data.

🔬 Have questions about testing or need analytical support for your products or research?
 📞 Contact our team: (619) 356-0898 🌐 Visit: www.sdpharmlabs.com 📩 Request a quote or consultation today.

08/12/2025

Protect Your Products with Heavy Metal Testing 🧪🌱

Quality starts with what you can’t see. Heavy metals like lead, arsenic, cadmium, and mercury may be invisible, but their impact on product safety and compliance is significant. That’s why PharmLabs uses state-of-the-art ICP-MS instrumentation to detect even the smallest trace levels helping brands stay compliant, transparent, and trusted.

❓ Did you know? Some heavy metals naturally occur in soil, meaning even clean, organic cultivations can test positive without proper monitoring. Regular testing protects your customers and your brand’s reputation.

With years of experience across cannabis, h**p, mushroom, peptide, and wellness products, our team delivers fast, accurate results backed by ISO 17025 accreditation and strict scientific standards.

📞 Contact Us: Phone: (619) 356-0898 Website: www.sdpharmlabs.com
 🔍 Ready to safeguard your products? Request your heavy metal test today and elevate your brand’s quality with PharmLabs.
 

Address

3421 Hancock Street

92110

Opening Hours

Monday	09:00 - 17:00
Tuesday	09:00 - 17:00
Wednesday	09:00 - 17:00
Thursday	09:00 - 17:00
Friday	09:00 - 17:00

Telephone

(619) 356-0898

Website

http://sdpharmlabs.com/

Alerts

Be the first to know and let us send you an email when PharmLabs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to PharmLabs:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic?

Country:

City:

Our Story

PharmLabs provides the cannabis community with lab testing and analytical services to ensure consumers have access to safe medicine. We offer informational testing for consumers and quality assurance purposes as well as full California Compliance testing including Random Sampling; your required first step towards Compliance which is performed by a trained Specialist.